Philipp Spycher is the CSO at Araris Biotech AG and the inventor of the Araris ADC Technology. He has a profound background in Bioconjugation and ADCs and during his post-doctoral work at the Paul Scherrer Institute (PSI, Switzerland), he introduced the novel approach using transglutaminases for antibody conjugation that led to the discovery of the Araris ADC Technology. Philipp won the PSI Founder Fellowship as well as several other prices and grants to commercialize the technology. He obtained his Master’s Degree and Ph.D. from ETH Zurich (Switzerland) at the interface of Material Science and Protein Engineering.
Philipp Spycher
